WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Stock Ownership - Who owns Bioxcel Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Bioxcel Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Frank YoccaChief Scientific Officer2024-04-041,067$2.64
$2.81kSell
Vimal MehtaCEO and President2024-04-044,439$2.63
$11.65kSell
Vimal MehtaCEO and President2024-04-04829$2.62
$2.17kSell
Vincent OneillExecutive Vice President Chief of Product Development and Medical Officer2024-04-04165$2.62
$432.47Sell
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2024-04-041,012$2.64
$2.67kSell
Richard I. SteinhartChief Financial Officer2024-04-041,069$2.64
$2.82kSell
Matthew T. WileyCHIEF COMMERCIAL OFFICER2024-04-041,008$2.64
$2.66kSell
Vimal MehtaCEO and President2023-06-1630,000$0.41
$12.30kBuy
Vimal MehtaCEO and President2023-06-16747$21.89
$16.35kSell
Vimal MehtaCEO and President2023-06-164,266$20.90
$89.16kSell

1 of 2

BTAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTAI insiders and whales buy or sell their stock.

BTAI Shareholders

What type of owners hold Bioxcel Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vimal Mehta84.00%25,685,814$76.29MInsider
Bioxcel Holdings Inc57.45%17,566,750$52.17MInsider
Krishnan Nandabalan55.91%17,094,500$50.77MInsider
Vipin Agarwal27.98%8,554,945$25.41MInsider
Rashmi Agarwal27.98%8,554,945$25.41MInsider
Tarun K. Gupta27.96%8,550,396$25.39MInsider
Indu R. Gupta27.96%8,550,396$25.39MInsider
Suganthi Balasubramanian27.96%8,547,750$25.39MInsider
Anita Jain27.95%8,547,300$25.39MInsider
Diwakar Jain27.95%8,547,300$25.39MInsider

1 of 3

BTAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTAI4.33%95.67%Net SellingNet Selling
ALRN3.39%96.61%Net Buying
HOOK35.22%26.83%Net Buying
LPTX12.25%87.75%
RVPH18.78%38.25%
View Top Biotech Stocks

Bioxcel Therapeutics Stock Ownership FAQ

Who owns Bioxcel Therapeutics?

Bioxcel Therapeutics (NASDAQ: BTAI) is owned by 30.48% institutional shareholders, 673.72% Bioxcel Therapeutics insiders, and 0.00% retail investors. Vimal Mehta is the largest individual Bioxcel Therapeutics shareholder, owning 25.69M shares representing 84.00% of the company. Vimal Mehta's Bioxcel Therapeutics shares are currently valued at $69.61M.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.